Successful Treatment of Relapsed Acquired Amegakaryocytic Thrombocytopenia with Repeat Cyclosporine
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Acquired amegakaryocytic thrombocytopenia (AAMT) is an unusual disease characterized by severe thrombocytopenia resulting from a marked decrease in bone marrow megakaryocytes. Various pathogenic mechanisms have been suggested, and several treatments have been tried, with varying outcomes. In some case reports, cyclosporine and anti-thymocyte globulin have had good clinical results in the treat of AAMT. There are few reports on the treatment of relapsed AAMT with cyclosporine. We report a patient with relapsed AAMT who was treated successfully with an additional course of cyclosporine. The initial remission was achieved with cyclosporine 4 years earlier and a second remission was induced by cyclosporine. Cyclosporine may be effective for relapsed AAMT that previously responded to cyclosporine.
Abstract
Acquired amegakaryocytic thrombocytopenia (AAMT) is an unusual disease characterized by severe thrombocytopenia resulting from a marked decrease in bone marrow megakaryocytes. Various pathogenic mechanisms have been suggested, and several treatments have been tried, with varying outcomes. In some case reports, cyclosporine and anti-thymocyte globulin have had good clinical results in the treat of AAMT. There are few reports on the treatment of relapsed AAMT with cyclosporine. We report a patient with relapsed AAMT who was treated successfully with an additional course of cyclosporine. The initial remission was achieved with cyclosporine 4 years earlier and a second remission was induced by cyclosporine. Cyclosporine may be effective for relapsed AAMT that previously responded to cyclosporine.
참고문헌 (10)
- Hoffman R, "Acquired amegakaryocytic thrombocytopenic purpura : a syndrome of diverse etiologies", Blood, 60, pp.1173~1178 (1982)
- Agarwal N, "Acquired amegakaryocytic thrombocytopenic purpura", Am J Hematol, 81, pp.132~135 (2006)
- Doubek M, "Megakaryocyte colony-forming unit growth is enhanced by alemtuzumab : in vitro experiments and a case report of acquired amegakaryocytic thrombocytopenic purpura", Leukemia, 20, pp.1618~1619 (2006)
- Quintás-Cardama A, "Acquired amegakaryocytic thrombocytopenic purpura successfully treated with limited cyclosporin A therapy", Eur J Haematol, 69, pp.185~186 (2002)
- Niparuck P, "Successful treatment of acquired amegakaryocytic thrombocytopenic purpura refractory to corticosteroids and intravenous immunoglobulin with antithymocyte globulin and cyclosporin", Int J Hematol, 88, pp.223~226 (2008)
- Chaudhary UB, "Acquired amegakaryocytic thrombocytopenia purpura and eosinophilic fasciitis : a long relapsing and remitting course", Am J Hematol, 75, pp.146~150 (2004)
- Ho S, "The mechanism of action of cyclosporin A and FK506", Clin Immunol Immunopathol, 80(3 Pt 2), pp.40~45 (1996)
- Marsh JC, "Guidelines for the diagnosis and management of aplastic anaemia", Br J Haematol, 147, pp.43~70 (2009)
- 신승환, "Recent advances in treatment of aplastic anemia", The Korean Journal of Internal Medicine, 29(6), pp.713~726 (2014), 대한내과학회[DOI]
- Shigekiyo T, "Treatment of acquired amegakaryocytic thrombocytopenic purpura with romiplostim", Platelets, 26, pp.504~506 (2015)